• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Packaging Technology

    Elemental Impurities: The Time Has Come

    Continuous vs. Batch Production

    2018: The evolution of pharmaceutical packaging

    Formulation Development Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Sterling Pharma Invests £6M To Expand Offerings

    Bioclinica Announces Key Hires & Promotion

    PhoenixMD, STA Enter Manufacturing Agreement

    ProBioGen, Tizona Therapeutics Enter Collaboration

    Mayne Pharma Opens $80M Oral Solid Dose Facility
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Arcinova Receives £1.5M Innovate UK Grant

    Vetter Announces Visit from Illinois Governor

    Sterling Pharma Invests £6M To Expand Offerings

    PhoenixMD, STA Enter Manufacturing Agreement

    Mayne Pharma Opens $80M Oral Solid Dose Facility
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    INTERPHEX: Adents Showcases Cloud-Based Serialization Solution

    Almac Group Expands Packaging Capabilities

    Catalent Bolsters Clinical Supply Capabilities

    West, Stevanato Group Enter Ompi EZ-fill Alliance

    Pharmaceutical Packaging Technology
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Sterling Pharma Invests £6M To Expand Offerings

    PhoenixMD, STA Enter Manufacturing Agreement

    ProBioGen, Tizona Therapeutics Enter Collaboration

    INTERPHEX: Adents Showcases Cloud-Based Serialization Solution

    SAMDI Tech Enters Drug Discovery Collaboration
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Blockchain: The Next Big Trend in BioPharma?

    Emergent Completes Market Authorization

    Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle: ICH Q12

    LSNE Expands Capabilities and QC Laboratory Space

    Evotec Launches Drug Development Service
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    IQVIA

    Dow Development Laboratories, LLC

    Almac Group

    Unither Pharmaceuticals

    Avista Pharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Manufacturing Equipment Trends

    Industry perspective from suppliers and manufacturers

    Related CONTENT
    • Solid Dosage Manufacturing Trends
    • Combatting the Counterfeiters
    • The Premier Source for Pharmaceutical Process and Packaging Equipment
    • Contract Packaging Update
    • Tablet Defect Technology Symposium
    Kristin Brooks, Associate Editor03.07.12
    While the pharmaceutical industry has been wrestling with cost-cutting restructuring initiatives, the lingering recession, healthcare mandates and patent expiries, R&D has brought forth sophisticated new therapies that have impacted equipment trends. Continuous production, advanced technology, and flexibility, from development to scale up, are in high demand among pharma/biopharma manufacturers. These must-haves are pervasive as they relate to manufacturing, processing and packaging.
     
    To support the latest development innovations in pharma and biopharma therapies, as well as advances or improvments to manufacturing processes, equipment manufacturers are incorporating more flexibility through automation, single-use technologies and user-friendly software.
     
    Equipment Trends
    Regulatory requirements, containment of highly potent substances, small batch sizes, personalized medicine, and the use of disposable technologies in biopharmaceutical production: these have all made their mark on the equipment landscape. Dr. Elke Sternberger-Rützel, a Pharma Trendscout for Robert Bosch GmbH, Packaging Technology Pharma Business Unit, said, "To keep pace with advances in drug research and development, such as high-potency treatments, engineering expertise is required to design equipment that can handle, package and secure such substances. Pharmaceuticals, biopharmaceuticals, vaccines and antivirals must be manufactured and packaged with the utmost caution and attention to detail. It is with these requirements in mind that we see four particular trends emerging in the field of pharmaceutical processing and packaging equipment, namely: the ability to handle potent substances; adapting lines for personalized medicine; increasing use of disposable components, and anti-counterfeiting."
     
    So, what are clients are looking for in equipment? They're looking for nothing short of advanced, high-efficiency processing equipment that's easy-to-use, and spans development to scale up. Elle Nolte, manager of Processing Technology at L.B. Bohle LLC, commented, "Manufacturers are looking into technologies that can be used for the development of drug products and then the same unit(s) can be used for production in larger scale, just in longer timeframes. That eliminates a complete step (the scale up to larger production units) in product development. As that saves a significant amount of time during the period the products are under license, profit will rise accordingly. Usually the loss of time in a production process development is inversely proportional to the profit out of it."
     
    For the handling of highly potent drugs, the latest equipment solutions favor the use of automation and robotics technology to reduce human contact with any substances that are being manufactured. According to Dr. Sternberger-Rützel, "Advanced automation has the simultaneous benefits of flexibility (replacing inflexible, standard conveyor belts) and increased line efficiency, further enhancing its attractiveness to forward-thinking drug manufacturers." 
     
    Also, tailored drug production for a greater variety of products, with smaller batch sizes and frequent changeover, has led to the need for greater flexibility with manufacturing and packaging solutions. Moving away from standard dosage products, there is a greater need for more product specific packaging using a greater variety of materials. To accommodate these needs, said Dr. Sternberger-Rützel, "The latest solutions are built to withstand frequent changeovers and can be adapted to different types of containers through adjustable robotic handling equipment and operating systems that can be controlled at the touch of a button. The latest filling and closing machines are able to handle different sizes of stoppers, caps and vials, allowing for simple changeovers between low-volume production runs. Flexibility is further enhanced by the ability to switch between different filling systems, including disposable rolling diaphragm pumps, or peristaltic pumps with single-use hoses."
     
    With heightened use of analytical technology, complete automation and real-time monitoring have become must-haves. David Higgs, head of marketing at Malvern Instruments Ltd., remarked, "When it comes to analytical instrumentation, the trend is towards continuous process analysis, a prime aim for many people being the complete automation of control. Customers continue to look to new instrumentation to deliver more information, more efficiently. Ease of use is a major issue for laboratory throughput and as products become more sophisticated, instruments that provide new layers of insight are increasingly important."
     
    He added, "In formulation, development and manufacture, the pharmaceutical industry's use of analytical technology is growing as the industry increasingly focuses on efficient production.  This includes the use of process analytical technology (PAT), associated with in- and on-line instrumentation that provides real-time process monitoring."
     
    Currently, some lab hurdles are being addressed by sophisticated programs for machine controls and interactive features with software designed for users of all experience levels. For analytical instruments, intelligent software that fully automates system functions and guides users through the measurement process is proving to add the greatest value. According to Malvern's Mr. Higgs, "Our most recent instrument development programs have focused heavily in this area. For instance, the new Mastersizer 3000 particle size analyzer has software with embedded support that assists at every stage of measurement so that all users – experienced or novice – can make reliable measurements. Today, few users are expert in specific analytical technologies and are required to use many different instruments and methodologies. Lightening the analytical workload with easy to use, intuitive instruments and intelligent software is essential."
     
    Mr. Higgs also noted, "In the process arena the use of in- and on-line analyzers is increasingly widespread but they only fulfill their ultimate potential when used for automated control. Software now exists that enables the development of control architectures that can acquire and use data from a diverse array of different analyzers, eliminating the need for multiple dedicated solutions. This transforms analyzer integration for automated control from being a costly, bespoke task for each individual plant, to becoming a more rapid, routine and cost-effective procedure."
     
    Equipment Challenges
    Pervasive regulatory requirements and complicated instrumentation have heightened the need for advanced yet user-friendly solutions.
     
    Matt Hicks, chief operating officer, Federal Equipment Co., a seller of surplus processing equipment, said, "We see a great opportunity for new solutions in aseptic manufacturing and fill-finish activities. These are very complex manufacturing processes and techniques with strict regulatory oversight and manufacturers of these products have made their way into headlines lately because of drug shortages and quality issues. With many new products planed for vials as well as many life-saving products already in vials, we expect to see equipment manufacturers develop engineered solutions to address the problems this segment of the industry currently faces."
     
    Easy operation of highly sophisticated equipment, coupled with processes that are less than par, can also present some challenges. Mr. Nolte at L.B. Bohle said, "Even though processes are sometimes not the best and robust processes that could be developed, clients want to produce AAA products. Lack of time during process development and low level of process understanding very often ends in suboptimal processing with a lot of manual intervention. To straighten that out as much as possible, excellent proportional, integral, derivative (PID) controlled processing has to be developed when changing over to new equipment, which needs simple to operate and highly sophisticated (in terms of control capabilities) operator interfaces and control systems." These controllers are designed to eliminate the need for an operator’s continuous attention, much like autopilot.
     
    In an effort to provide the most efficient and comprehensive processes, some equipment manufactures, as well as technology providers, are combining expertise to create products that address these industry needs. For example, Malvern Instruments, along with collaborators ARTMiS and Powder Systems Ltd. (PSL), have created a new milling suite that incorporates ARTMiS' Automated RealTime Milling System within PSL's containment unit, which is designed to provide a secure, advanced processing solution for highly potent and/or high value materials. ARTMiS brings Sturtevant's Micronizer Jet Mill together with a Malvern Insitec particle size analyzer and the Schenck AccuRate PureFeed Feeder to deliver a fully automated system for jet milling, aimed at providing exemplary process control for optimal manufacturing efficiency. Built on the expertise of all three companies, it's designed to simplify and optimize the jet milling process and reduce operational requirements. "Companies like ours increasingly work in partnership with other technology providers to engineer a complete solution for process analysis and control. Its installation within PSL's advanced containment unit extends all of these benefits to those handling toxic or hazardous materials, such as pharmaceutical actives," said Malvern's Mr. Higgs.
     
    Single Use Technologies
    The biopharmaceutical industry is increasingly incorporating single-use technologies to address cost pressures, reduce risk and accelerate the biomanufacturing process. Disposable systems, in addition to convenience, relieve the risk of cross-contamination. Dr. Sternberger-Rützel at Bosch noted, “The trend towards disposable components is a consequence of industry safety regulations, growing use of highly potent substances, and a shift towards smaller batch sizes. The time-consuming process of cleaning, sterilizing and validating product contact parts, particularly during changeovers, has long been a hindrance in achieving operational efficiency. Disposable, pre-sterilized and pre-validated parts including hoses, product bags, filling needles and tubing remove this inefficiency and can eliminate the loss of capacity resulting from lengthy cleaning validation as well as the risk of contamination between batch runs.”
     
    Additionally, low-volume capabilities that allow for using the smallest amount of material possible are essential for analyzing biological materials. Malvern’s Mr. Higgs pointed out, “Low-volume disposable polystyrene cuvettes for analytical instruments, such as the Zetasizer Nano particle characterization system, are enabling the size measurement of very small amounts of sample.”

    Disposable trends are on the rise and offer optimal conditions for manufacturing processes. According to Dr. Sternberger-Rützel, “In 2012, pharmaceutical manufacturers will be increasingly drawn to the simplicity and speed of disposable systems, which easily meet industry standards. Assembled in DIN ISO 14644-1 class 7 cleanrooms, the latest single-use components are connected to the product stream via sterile plug-and-play connections and are easily removed, bagged and disposed of without breaking connections and exposing the environment to the product.” 
     
    New vs. Used Equipment

    Investing in new or used equipment varies widely in the industry, contingent upon manufacturing needs, and cost is not necessarily a factor. “Big pharma uses used equipment to a certain extent, where possible. If for any reason a purchase of new equipment is faster, including qualification/validation, most of the time new equipment is the first choice, as time is money,” said Mr. Nolte at L.B. Bohle. “Used equipment can be more expensive than new equipment. The investment is not only the cost of hardware, it’s the overall cost including all planning and integration steps. The cost ratio between hardware and controls/documentation for new equipment for instance is constantly moving to the controls/documentation side. It can be as 50% for the hardware costs and 50% for the controls/documentation cost.”

    However, starting from scratch with the installation of new equipment can be more time consuming, particularly for existing manufacturing processes and projects. Mr. Hicks at Federal Equipment noted, “Our customers routinely seek out both new and used equipment depending upon their own manufacturing mix and given opportunities. With a short timeframe to get a new product launched, used equipment becomes a much more viable option over new equipment. If the need is for spares, replacement equipment, or additional capacity with similar equipment, used equipment is always a lower cost option. However, new products sometimes require very specific, custom-built equipment. The more specialized the piece of equipment, the harder it is to source on the secondary market, which favors the purchase of new equipment.”   

    “For packaging and processing equipment suppliers it is vital to be abreast of the trends and to develop machinery that helps manufacturers deal with the increasing demands of a changing environment, and to develop solutions tailored to meet their needs,” said Dr. Sternberger-Rützel.

    Equipment for the latest manufacturing processes, containment solutions for a growing HPAPI segment, flexibility of scale for new therapies such as personalized medicine, and short start-up times and easy changeovers are on trend and equipment providers are charged with designing the equipment that can manufacture and package these increasingly complex drug products. Whether making repairs to existing equipment or purchasing new or used, equipment is integral to a reliable manufacturing process that produces quality product on a regular basis and having all of these options are essential. 
     


    Kristin Brooks is the associate editor of Contract Pharma. She can be reached at kbrooks@rodpub.com.
    Related Searches
    • Pharma
    • Sterile
    • Biomanufacturing
    • Manufacturing
    Suggested For You
    Solubility Enhancement: Novel Approaches to Rational Formulation Choice Solubility Enhancement: Novel Approaches to Rational Formulation Choice
    Drug Development in Today’s Changing Healthcare Market Drug Development in Today’s Changing Healthcare Market
    Ashland Opens Expanded Technical Center in Shanghai Ashland Opens Expanded Technical Center in Shanghai
    Photos from INTERPHEX Show Floor Photos from INTERPHEX Show Floor
    Packaging Equipment Close-Up Packaging Equipment Close-Up
    AAI/CML Expands Sterile Fill-Finish Capabilities  AAI/CML Expands Sterile Fill-Finish Capabilities
    Metrics Contract Services to Offer ‘Concept to Commercialization’ with Expanded Facility Metrics Contract Services to Offer ‘Concept to Commercialization’ with Expanded Facility
    Potent Products Potent Products
    Newsmakers: Intellicentic Newsmakers: Intellicentic
    L.B. Bohle Opens New Facility in Germany L.B. Bohle Opens New Facility in Germany
    Tablet Defect Technology Symposium Tablet Defect Technology Symposium
    Contract Packaging Update Contract Packaging Update
    The Premier Source for Pharmaceutical Process and Packaging Equipment The Premier Source for Pharmaceutical Process and Packaging Equipment
    Combatting the Counterfeiters Combatting the Counterfeiters
    Solid Dosage Manufacturing Trends Solid Dosage Manufacturing Trends

    Related Online Exclusives

    • Bio News | Industry News | Validation
      Blockchain: The Next Big Trend in BioPharma?

      Blockchain: The Next Big Trend in BioPharma?

      Accenture Life Sciences' Carly L. Guenther shares her thoughts on the future of blockchain in supply chain management
      Betsy Louda, Associate Editor 04.13.18

    • Biologic Sample Management in R&D

      Biologic Sample Management in R&D

      Vyas of PAREXEL discusses the significance of biologic samples, sample management challenges and the regulatory implications
      Kristin Brooks, Managing Editor 02.15.18

    • Bio News | Industry News
      Weill Cornell Joins the TriNetX Network

      Weill Cornell Joins the TriNetX Network

      The move makes their total patient population of over two million available for query through the platform
      02.08.18


    • cGMP Manufacture
      Advantages of Fixed-Dose Combo Drug Products

      Advantages of Fixed-Dose Combo Drug Products

      Dr. Anthony Qu of Halo discusses opportunities in this growing market
      Kristin Brooks, Contract Pharma 11.14.17

    • APIs | cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Serialization | Supply Chain

      U.S. Pharma Market Trends

      CPhI Report sees return of generic and API manufacturing to U.S. market
      Kristin Brooks, Contract Pharma 04.08.16

    • APIs | Logistics | Solid Dosage/Creams/Ointments | Supply Chain

      DCAT Week ’16 Session Highlights

      API and Dose CMO Market Trends and Supply Strategies
      Kristin Brooks, Contract Pharma 03.24.16


    • Capsules | cGMP Manufacture | Facilities | Solid Dosage/Creams/Ointments | Supply Chain
      Talking Trends with Aesica

      Talking Trends with Aesica

      Managing director Ian Muir fills us in on the latest at the CDMO
      Tim Wright, editor 02.26.16

    • Inspections | QA/QC | Regulatory Affairs | Serialization
      2015 Contracting & Outsourcing Wrap-up

      2015 Contracting & Outsourcing Wrap-up

      A huge success, with another year of record attendance, sold-out exhibit hall, and a great line up of informative sessions
      Kristin Brooks, Contract Pharma 09.30.15

    • Capsules | Excipients | GMPs/GCPs | Industry News | Inspections | Process Development | Regulatory Affairs | Solid Dosage/Semi-solids

      Molecular Profiles Hosts Bioavailability Event

      Biannual event attracts scientists, executives
      Gil Roth 02.11.14


    • APIs | Capsules | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Industry News | Inspections | Lyophilization | Process Development | QA/QC | Regulatory Affairs | Serialization | Supply Chain | Validation

      FDA Publishes Report on GDUFA

      First-year goals met
      Gil Roth 02.05.14

    • CRO News | GMPs/GCPs | Inspections | Process Development | Regulatory Affairs

      PAREXEL Creates Customized Biopharm Unit

      Q&A with Ubavka DeNoble, M.D. about small and mid-size company needs
      Kristin Brooks 11.06.13

    • APIs | Aseptic Processing | Capsules | Cleaning Validation | Clinical Trial Materials | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Industry News | Inspections | Lyophilization | Process Development | QA/QC | Regulatory Affairs | Serialization | Solid Dosage/Semi-solids | Supply Chain | Validation

      European Medicines Agency Reveals New Structure

      EMA reorganizes to cover drugs' lifecycles
      Gil Roth 09.16.13

    • WIL Research Acquires Ricerca Lyon

      CEO David Spaight explains geographic, capacity play
      Gil Roth 08.26.13

    • CRO News | Validation

      CrownBio-PRECOS Acquisition

      Crown Bioscience's president talks about this preclinical play
      Kristin Brooks 08.21.13

    • Aseptic Processing | Capsules | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Inspections | Lyophilization | Parenterals | Process Development | QA/QC | Regulatory Affairs | Serialization | Solid Dosage/Semi-solids | Supply Chain | Validation | Vials
      West Pharmaceutical Services Q&A

      West Pharmaceutical Services Q&A

      We talk with West CEO Don Morel about the company's 90th anniversary
      Gil Roth 07.11.13

    Breaking News
    • Sterling Pharma Invests £6M To Expand Offerings
    • AGC Chemicals to Feature Advanced Intermediates
    • Avema to Showcase Range of Services
    • Peter Stein to Deliver FDA Keynote Presentation
    • CPhI NA Conference to Focus on Fostering Innovation
    View Breaking News >
    CURRENT ISSUE

    April 2018

    • Pharmaceutical Packaging Technology
    • Elemental Impurities: The Time Has Come
    • Continuous vs. Batch Production
    • 2018: The evolution of pharmaceutical packaging
    • Formulation Development Trends
    • Changing Dynamics: The CDMO market in focus
    • Contract BioManufacturing in China: Creating a New Segment
    • View More >

    Copyright © 2018 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.